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Abstract
The objective of the research was to study myocardial hemodynamics and contractility, as well as N-terminal
pro-brain natriuretic peptide secretion in the patients with chronic coronary artery disease depending on affected
coronary artery number according to coronary angiography.
Materials and methods. The study included 62 patients with chronic coronary artery disease, heart failure
with preserved left ventricular ejection fraction. Among the examined patients, males prevailed – 52 (83.9%)
individuals. The average age was 61.2±1.2 years. The control group included 15 apparently healthy individuals
with preserved gender and age proportions. The patients were randomized by the number of the affected
coronary arteries and divided into 2 subgroups according to the results of coronary angiography. Subgroup
I included 16 (25.8%) patients with single-vessel coronary artery disease; subgroup II comprised 46 (74.2%)
patients with multivessel coronary artery disease.
Results and discussion. According to Holter monitoring, average and maximum heart rate, extrasystoles and
episodes of ST-segment depression/elevation were more often found in the patients with multivessel coronary
artery disease (p<0.05). According to echocardioscopy, in the patients with coronary artery disease regardless
of affected coronary artery number, hemodynamic indicators were higher as compared to healthy individuals
(p<0.001), while left ventricular ejection fraction was lower in the patients with multivessel coronary artery
disease (p<0.001). Serum level of N-terminal pro-brain natriuretic peptide exceeded reference value in both
single-vessel coronary artery disease and multivessel coronary artery disease (p<0.001); however, the secretion
of this peptide increased in multivessel coronary artery disease (p<0.05). There was observed a strong inverse
correlation between left ventricular ejection fraction and N-terminal pro-brain natriuretic peptide in the patients
with multivessel coronary artery disease and a moderate correlation in the patients with single-vessel coronary
artery disease.
Conclusions. The nature and severity of coronary artery disease clinical course are associated with the number
of the coronary arteries affected by atherosclerotic plaques. In multivessel coronary artery disease, according to
the results of clinical, functional and laboratory studies, there was observed persistent progression of coronary
artery disease and, consequently, chronic heart failure that is the reason for the improvement of schemata for
successful treatment of the disease.
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Problem statement and analysis of
the latest research
The study of overall morbidity showed that circu-
latory system diseases rank high among all disease
categories accounting for 30.6% of all the cases [3].
In recent years, there has been a tendency for a two-
fold increase in cardiovascular disease incidence
and a three-fold increase in their prevalence [5, 9].
Cardiovascular disease is one of the leading causes
of primary disability and mortality among the adult
population. Coronary artery disease (CAD) which
leads to structural and functional changes in the
heart is the first ranked and most common pathol-
ogy affecting the adult population [8].
Left ventricular (LV) dysfunction that occurs
due to recurrent or prolonged ischemia often pre-
cedes the reduction in its ejection fraction (EF) and
the impairment of systemic hemodynamics, affects
heart rate (HR) and provokes premature ventricular
contractions which manifest themselves as extrasys-
toles of various localization [2, 4]. Change in LV
shape throughout the cardiac cycle from more ellip-
tical during systole to more spherical during dias-
tole is a normal component of systolic and diastolic
functions [6]. Minor LV lengthening during systole
is a mechanism by which the ventricle pushes out
greater amount of blood in case of less myocardial
stress. During diastole, LV spherization is accom-
panied by an increase in LV cavity volume and
complements the process of early diastolic filling
[7].
Volume overload of the heart and ischemia lead
to myocardial wall tension that results in biome-
chanical stress which induces the secretion of N-
terminal pro-brain natriuretic peptide (NT-pro-BNP)
by cardiomyocytes [1]. The mechanism of NT-pro-
BNP action consists in the modulation of vascular
tone, increase in natriuresis and the activity of the
sympathoadrenal and renin-angiotensin systems; it
has miotic, proliferative and proapoptotic effects
[10, 11]. Changes in BNP levels are observed in
case of heart failure, acute coronary syndrome, as
well as chronic CAD. High NT-pro-BNP concentra-
tion is an independent predictor of the deterioration
in the patient’s condition and the development of
recurrent ischemic events.
The objective of the research was to analyze
correlation between the indicators of Holter moni-
toring (HM), echocardioscopy (EchoCS), NT-pro-
BNP depending on affected coronary artery (CA)
number in the patients with chronic CAD.
1. Materials and Methods
The study included 62 patients with chronic CAD,
heart failure with preserved LVEF who were sub-
mitted to CA stenting. The study was carried out in
the Ivano-Frankivsk Regional Clinical Cardiology
Center and Ivano-Frankivsk Central City Hospi-
tal; regular medical check-ups were carried out in
municipal polyclinics. Among the examined pa-
tients, males prevailed – 52 (83.9%) individuals.
The average age was 61.2±1.2 years. The control
group included 15 apparently healthy individuals
with the average age of 60±0.8 years. According to
the results of coronary angiography (CAG), all the
patients were randomized depending on the num-
ber of the affected CA and divided into two sub-
groups: subgroup I included 16 (25.8%) patients
with single-vessel coronary artery disease (CAD);
subgroup II comprised 46 (74.2%) patients with
multivessel CAD.
All the patients underwent clinical and labora-
tory examination in accordance with the Unified
Clinical Protocol of Primary, Secondary (Special-
ized) and Tertiary (Highly Specialized) Medical
Care ”Chronic Coronary Artery Disease” (2016),
the recommendations of the European Society of
Cardiology (ESC) ”ESC Guidelines for the Diag-
nosis and Treatment of Acute and Chronic Heart
Failure 2012” and the guidelines of the Ukrainian
Heart Failure Association (2017).
HM was carried out using the electrocardio-
graphic complex KardioLab (Hai-Medica, Kharkiv,
Ukraine)
To assess the structural and functional state of
the myocardium and intracardiac hemodynamics,
there was performed EchoCS by means of Philips
Hd11xe ultrasound machine (Germany) using 2.5
MHz transducer and B- and M-Modes. There were
determined LV end-diastolic dimension (EDD), LV
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end-systolic dimension (ESD) and their indices,
LV end-diastolic volume (EDV), LV end-systolic
volume (ESV) and their indices, LVEF, functional
derivatives of the studied chambers.
All the patient underwent CAG. There were
used the Infinix CC-i/FPD angiographs manufac-
tured by Toshiba Medical Systems Corporation
(Japan). CAG procedures were performed via radial
artery access. The following contrast agents were
used – Ultravist 370 mg/ml, Omnipaque 350 mg/ml,
or Visipaque 320 mg/ml.
Serum concentration of NT-pro-BNP was de-
termined by means of the IMMULITE 2000 im-
munoassay system (Siemens, USA) using commer-
cial ELISA kits (Biomedica Medizinprodukte
GmbH&Co KG, Vienna, Austria) according to the
method proposed by the manufacturer.
To objectively assess the reliability of the re-
search results, variational statistical analysis of the
results obtained was conducted on a Pentium II
PC using the Statistica 8.0 software package and
Microsoft Excel statistical functions.
2. Results and Discussion
According to 24-hour HM of the patients with chronic
CAD (Table 1), average HR in the patients with
single-vessel CAD and multivessel CAD was 19.3%
and 25.8% higher than that in healthy individuals
(p<0.001). In single-vessel CAD, average HR was
8.03% lower as compared to the patients with mul-
tivessel CAD (p<0.05). The indicator of maxi-
mum HR in both subgroups was 22.4% and 32.4%
higher than that in healthy individuals (p<0.05 and
p<0.001), respectively. In the patients with single-
vessel CAD, maximum HR was 12.8% lower as
compared to the patients with multivessel CAD
(p<0.05). The difference in minimum HR between
healthy individuals and the patients with single-
vessel CAD and multivessel CAD was 9.2% and
16.5% (p<0.001).
Ischemic myocardium resulted in pain, as well
as an 8-fold increase in tachycardia episodes as com-
pared to healthy individuals in multivessel CAD
(p<0.05). The electric instability of ischemic my-
ocardium changed as well: the number of ventric-
ular and supraventricular extrasystoles increased
by 10 times in multivessel CAD and by 9 times in
single-vessel CAD (p<0.05).
ST-segment episodes were 5.2% less recorded
in the patients with single-vessel CAD as compared
to the patients with multivessel CAD (p<0.05). In
the patients with single-vessel CAD, the duration
of ST-segment episodes and the QT interval was
9.5% and 2.9% lower as compared to the patients
with multivessel CAD and significantly differed in
their number from the group of healthy individuals
(p<0.001).
Prolonged ischemia episodes for many years
changed LV structure. The structural and functional
indicators of the heart in the patients with angina
depending on affected CA number are presented
in Table 2. The indicators of EchoCS, especially
LV volume indices, were found to depend on the
number of the affected CA. There was observed
an increase in EDV by 1.3 and 1.4 times and an
increase in ESV by 1.7 and 1.9 times, respectively
depending on affected CA number (p<0.05 and
p<0.01); an increase in left atrium (LA) size by
7.7% and 14.3% as compared to healthy individuals
(p<0.001). Prolonged chronic ischemia resulted
in the reduction in cardiac contractility by 8.4%
and 12.5%, respectively depending on affected CA
number (p<0.001).
Reduced LV contractility was confirmed by serum
level of the marker of CAD development and pro-
gression, namely NT-pro-BNP as well, indicating
volume overload of cardiomyocytes (Fig. 1).
In the patients with single-vessel CAD, the level
of NT-pro-BNP was 689.3±10.59 fmol/ml exceed-
ing that in healthy individuals by 3.9 times; in case
of multivessel CAD, it exceeded reference value
by 4.2 times (p<0.001). In the patients with mul-
tivessel CAD, the level of NT-pro-BNP was 8.4%
higher than that in the patients with single-vessel
CAD (p<0.05).
When studying the relationship between car-
diac volumetric parameters and NT-pro-BNP level
depending on affected CA number (Fig. 2, 3),
there was observed a strong inverse correlation be-
tween LV EF and serum NT-pro-BNP level (r=-0.89,
p<0.001 and r=-0.86, p<0.001).
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Table 1. Indicators of 24-hour HM in the patients with chronic CAD, heart failure with preserved LVEF
depending on affected CA number (M±m)
Indicators
Patients, n = 62
Healthy individuals, Single-vessel CAD, Multivessel CAD,
n=15 n = 16 n = 46
1 2 3
Average HR/min 66.5±2.17
82.4±2.96 89.6±1.62
p1-2<0.001 p1-3<0.001
p2-3<0.05
Maximum HR/min 102.2±6.18
131.7±10.31 151.1±6.41
p1-2<0.05 p1-3<0.001
p2-3<0.05
Minimum HR/min 45.2±0.13
49.8±1.27 54.1±1.68
p1-2<0.001 p1-3<0.001
p2-3<0.05
Tachycardia, number of
episodes/24 hour
9.4±0.16
69.4±0.47 73.0±1.17
p1-2<0.001 p1-3<0.001
p2-3<0.05
Supraventricular
extrasystoles/24 hour
369.2±16.17
3120.31±190.93 3623.15±121.25
p1-2<0.001 p1-3<0.001
p2-3<0.05
Ventricular
extrasystoles/24 hour
373.1±23.15
3358.12±206.69 3994.24±201.27
p1-2<0.001 p1-3<0.001
p2-3<0.05
ST-segment episodes, number 0 45.6±0.59 48.1±1.08
p2-3<0.05
Duration of ST-segment
depression/elevation/min/24 hour
0 326.2±6.86 360.5±11.62
p2-3<0.01
Average duration of the
QT interval/ms
372.1±4.46
361.4±0.97 358.4±0.35
p1-2<0.05 p1-3<0.01
p2-3<0.01
Prolonged angiospasm resulting in myocardial
ischemia which occurs in stable angina leads to
LV remodeling that is reflected by the reduction
in its EF. Such structural and functional changes
in the myocardium cause the reduction in cardiac
functional reserves and impair its contractility.
The optimization of schemata for successful
CAD treatment through the combination of mini-
mally invasive CA surgeries and traditional pharma-
cotherapy adding f-channel inhibitor of the sinoa-
trial node of the cardiac conduction system in the
therapeutic complex is promising that requires the
study of its effect on the structural and functional
state of the myocardium and its coronary reserve.
It is important to identify clinical and pathogenetic
predictors of chronic heart failure development and
progression in the patients with CAD who under-
went myocardial revascularization at various stages
and during different periods of rehabilitation treat-
ment; to determine the relationship between plasma
BNP level, clinical manifestations of chronic heart
failure, LV functional capacity and the period of
time that has passed since last endovascular in-
terventions on the background of optimized anti-
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Table 2. Indicators of EchoCS in the patients with chronic CAD, heart failure with preserved LVEF
depending on affected CA number (M±m)
Indicators
Patients, n = 62
Healthy individuals, Single-vessel CAD, Multivessel CAD,
n = 15 n = 16 n = 46
1 2 3
LA, cm 3.6±0.02
3.9±0.01 4.2±0.05
p1-2<0.001 p1-3<0.001
p2-3<0.001
LVEDD, cm 3.5±0.03
5.7±0.08 6.1±0.08
p1-2<0.001 p1-3<0.001
p2-3<0.001
LVESD, cm 2.6±0.06
4.3±0.07 4.6±0.08
p1-2<0.001 p1-3<0.001
p2-3<0.01
LVEDV, ml 138.0±0.71
173.4±2.70 187.2±5.53
p1-2<0.001 p1-3<0.001
p2-3<0.05
LVESV, ml 50.5±1.67
84.4±2.89 95.6±2.94
p1-2<0.001 p1-3<0.001
p2-3<0.01
LVEF, % 55.9±0.68
51.2±0.74 48.9±0.54
p1-2<0.001 p1-3<0.001
p2-3<0.05
ischemic pharmacotherapy.
3. Conclusions
HM and EchoCS are important diagnostic meth-
ods for examining the patients with angina on the
background of preserved LV contractile function.
According to 24-hour electrocardiography (ECG)
recording of the patients with chronic CAD, heart
failure with preserved LVEF depending on affected
CA number, average and maximum HR were higher
in the patients with multivessel CAD; minimum HR
was more often observed in the patients with single-
vessel CAD. The number of tachycardia episodes
was higher in multivessel CAD, while ventricu-
lar and supraventricular extrasystoles were equally
recorded in the patients of both subgroups. The
episodes of ST-segment depression/elevation were
more often found in the patients with multivessel
CAD (p<0.05).
The structural and functional LV parameters
changed depending on the degree of myocardial is-
chemia. Thus, in the patients with multivessel CAD,
the indicators of LVEDD, LVESD, LVEDV, LVESV
were higher than those in the patients with single-
vessel CAD. LVEF was significantly lower in the pa-
tients with multivessel CAD as compared to the pa-
tients with single-vessel CAD (p<0.05). Total my-
ocardial contractility was significantly lower in the
patients with multivessel CAD as compared to the
patients with single-vessel CAD as well (p<0.001).
Therefore, a ten-fold increase in NT-pro-BNP level,
which serves as a marker of chronic heart failure,
was observed in the patients with multivessel CAD
(p<0.001). There was observed a strong inverse
correlation between the parameters of LVEF and
the indicator of NT-pro-BNP in the patients with
multivessel CAD and a moderate correlation in the
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Figure 1. Plasma level of NT-pro-BNP in the patients with chronic CAD, heart failure with preserved
LVEF depending on affected CA number.
Notes: * – statistical significance of difference in the indicator between healthy individuals and the
patients with single-vessel and multivessel CAD (p<0.001); ∧ – statistical significance of difference in
the indicator between the patients with single-vessel CAD and those with multivessel CAD (p<0.05).
Figure 2. Correlation between EF and NT-pro-BNP in the patients with chronic CAD, heart failure with
preserved LVEF, single-vessel CAD.
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